Last updated on March 2018

A clinical trial seeking patients for a research study for the treatment of NIDDM

Brief description of study

This is a multi-center, randomised, double-blind, placebo-controlled, parallel-group, efficacy and safety study of empagliflozin as add-on to insulin in Japanese patients with Type 2 Diabetes Mellitus with insufficient glycaemic control

Clinical Study Identifier: NCT02589639

Contact Investigators or Research Sites near you

Start Over

Saiseikai Fukuoka General Hospital
Fukuoka, Fukuoka, Japan

Kunisaki Makoto Clinic
Fukuoka, Japan